Bio-Techne Corporation
TECHHealthcare|Biotechnology|US
$72.78
+0.12 (+0.17%)
DCF Value
$23.03
Tangible Book / Share
$5.78
Graham Number
$18.46
Cash / Share
$2.23
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06966089 ExosomeDx in MRI-negative Men With High PSA | Prostate Cancer | N/A | Not Yet Recruiting | 425 | Open-label | — |